Niagen Bioscience, Inc. (NAGE) CAPEX

Annual CAPEX:

$163.00K+$15.00K(+10.14%)
December 31, 2024

Summary

  • As of today, NAGE annual capital expenditures is $163.00 thousand, with the most recent change of +$15.00 thousand (+10.14%) on December 31, 2024.
  • During the last 3 years, NAGE annual CAPEX has fallen by -$246.00 thousand (-60.15%).
  • NAGE annual CAPEX is now -90.55% below its all-time high of $1.72 million, reached on December 1, 2016.

Performance

NAGE CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

Quarterly CAPEX:

$24.00K-$111.00K(-82.22%)
September 30, 2025

Summary

  • As of today, NAGE quarterly capital expenditures is $24.00 thousand, with the most recent change of -$111.00 thousand (-82.22%) on September 30, 2025.
  • Over the past year, NAGE quarterly CAPEX has dropped by -$17.00 thousand (-41.46%).
  • NAGE quarterly CAPEX is now -97.84% below its all-time high of $1.11 million, reached on June 1, 2018.

Performance

NAGE Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

TTM CAPEX:

$260.00K-$17.00K(-6.14%)
September 30, 2025

Summary

  • As of today, NAGE TTM capital expenditures is $260.00 thousand, with the most recent change of -$17.00 thousand (-6.14%) on September 30, 2025.
  • Over the past year, NAGE TTM CAPEX has increased by +$145.00 thousand (+126.09%).
  • NAGE TTM CAPEX is now -87.89% below its all-time high of $2.15 million, reached on June 1, 2018.

Performance

NAGE TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEcash flow metrics

NAGE CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+10.1%-41.5%+126.1%
3Y3 Years-60.1%-53.9%+58.5%
5Y5 Years-79.7%-44.2%-41.7%

NAGE CAPEX Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-60.1%+10.1%-86.0%+140.0%-35.0%+165.3%
5Y5-Year-79.7%+14.8%-90.9%+1100.0%-41.7%+165.3%
All-TimeAll-Time-90.5%>+9999.0%-97.8%>+9999.0%-87.9%>+9999.0%

NAGE CAPEX History

DateAnnualQuarterlyTTM
Sep 2025
-
$24.00K(-82.2%)
$260.00K(-6.1%)
Jun 2025
-
$135.00K(+321.9%)
$277.00K(+79.9%)
Mar 2025
-
$32.00K(-53.6%)
$154.00K(-5.5%)
Dec 2024
$163.00K(+10.1%)
$69.00K(+68.3%)
$163.00K(+41.7%)
Sep 2024
-
$41.00K(+241.7%)
$115.00K(+15.0%)
Jun 2024
-
$12.00K(-70.7%)
$100.00K(+2.0%)
Mar 2024
-
$41.00K(+95.2%)
$98.00K(-33.8%)
Dec 2023
$148.00K(-55.7%)
-
-
Dec 2023
-
$21.00K(-19.2%)
$148.00K(-50.5%)
Sep 2023
-
$26.00K(+160.0%)
$299.00K(-8.0%)
Jun 2023
-
$10.00K(-89.0%)
$325.00K(-18.8%)
Mar 2023
-
$91.00K(-47.1%)
$400.00K(+19.8%)
Dec 2022
$334.00K(-18.3%)
$172.00K(+230.8%)
$334.00K(+103.7%)
Sep 2022
-
$52.00K(-38.8%)
$164.00K(-21.2%)
Jun 2022
-
$85.00K(+240.0%)
$208.00K(-46.4%)
Mar 2022
-
$25.00K(+1150.0%)
$388.00K(-5.1%)
Dec 2021
$409.00K(+188.0%)
$2000.00(-97.9%)
$409.00K(-4.9%)
Sep 2021
-
$96.00K(-63.8%)
$430.00K(+14.1%)
Jun 2021
-
$265.00K(+476.1%)
$377.00K(+76.2%)
Mar 2021
-
$46.00K(+100.0%)
$214.00K(+13.8%)
Dec 2020
$142.00K(-82.3%)
$23.00K(-46.5%)
$188.00K(-57.8%)
Sep 2020
-
$43.00K(-57.8%)
$446.00K(-20.2%)
Jun 2020
-
$102.00K(+410.0%)
$559.00K(+6.3%)
Mar 2020
-
$20.00K(-92.9%)
$526.00K(-34.4%)
Dec 2019
$802.00K(-44.8%)
$281.00K(+80.1%)
$802.00K(+44.2%)
Sep 2019
-
$156.00K(+126.1%)
$556.00K(+15.4%)
Jun 2019
-
$69.00K(-76.7%)
$482.00K(-68.4%)
Mar 2019
-
$296.00K(+745.7%)
$1.53M(+9.7%)
Dec 2018
$1.45M(+7.4%)
$35.00K(-57.3%)
$1.39M(-15.8%)
Sep 2018
-
$82.00K(-92.6%)
$1.65M(-23.1%)
Jun 2018
-
$1.11M(+591.3%)
$2.15M(+84.0%)
Mar 2018
-
$161.00K(-45.5%)
$1.17M(-13.7%)
Dec 2017
$1.35M(-21.6%)
$295.30K(-48.8%)
$1.35M(-17.3%)
Sep 2017
-
$577.20K(+334.0%)
$1.64M(-8.0%)
Jun 2017
-
$133.00K(-61.6%)
$1.78M(-12.8%)
Mar 2017
-
$346.00K(-40.2%)
$2.04M(+18.2%)
Dec 2016
$1.72M
$578.90K(-19.6%)
$1.72M(+19.5%)
Sep 2016
-
$719.80K(+82.4%)
$1.44M(+58.2%)
DateAnnualQuarterlyTTM
Jun 2016
-
$394.60K(+1148.7%)
$912.30K(+57.7%)
Mar 2016
-
$31.60K(-89.4%)
$578.60K(-10.7%)
Dec 2015
$647.70K(+155.9%)
$297.50K(+57.7%)
$647.80K(+40.8%)
Sep 2015
-
$188.60K(+209.7%)
$460.00K(+43.1%)
Jun 2015
-
$60.90K(-39.6%)
$321.50K(-3.8%)
Mar 2015
-
$100.80K(-8.1%)
$334.30K(+32.1%)
Dec 2014
$253.10K(+11.8%)
$109.70K(+119.0%)
$253.10K(+38.2%)
Sep 2014
-
$50.10K(-32.0%)
$183.20K(-23.9%)
Jun 2014
-
$73.70K(+276.0%)
$240.60K(+21.2%)
Mar 2014
-
$19.60K(-50.8%)
$198.50K(-12.3%)
Dec 2013
$226.30K(+195.4%)
$39.80K(-63.0%)
$226.30K(+14.7%)
Sep 2013
-
$107.50K(+240.2%)
$197.30K(+39.5%)
Jun 2013
-
$31.60K(-33.3%)
$141.40K(+20.5%)
Mar 2013
-
$47.40K(+338.9%)
$117.30K(+53.1%)
Dec 2012
$76.60K(-56.6%)
$10.80K(-79.1%)
$76.60K(-15.0%)
Sep 2012
-
$51.60K(+588.0%)
$90.10K(+23.6%)
Jun 2012
-
$7500.00(+11.9%)
$72.90K(-41.5%)
Mar 2012
-
$6700.00(-72.4%)
$124.70K(-29.4%)
Dec 2011
$176.70K(-11.3%)
$24.30K(-29.4%)
$176.70K(-10.2%)
Sep 2011
-
$34.40K(-42.0%)
$196.80K(-5.2%)
Jun 2011
-
$59.30K(+1.0%)
$207.70K(+21.0%)
Mar 2011
-
$58.70K(+32.2%)
$171.60K(+1.4%)
Dec 2010
$199.10K(+7.9%)
$44.40K(-2.0%)
$169.20K(-37.9%)
Sep 2010
-
$45.30K(+95.3%)
$272.40K(+14.1%)
Jun 2010
-
$23.20K(-58.8%)
$238.70K(+3.9%)
Mar 2010
-
$56.30K(-61.9%)
$229.80K(+24.5%)
Dec 2009
$184.50K(-62.8%)
$147.60K(+1172.4%)
$184.60K(+68.4%)
Sep 2009
-
$11.60K(-18.9%)
$109.60K(-50.3%)
Jun 2009
-
$14.30K(+28.8%)
$220.70K(-56.5%)
Mar 2009
-
$11.10K(-84.7%)
$506.90K(+2.2%)
Dec 2008
$495.80K(>+9900.0%)
$72.60K(-40.8%)
$495.80K(+17.2%)
Sep 2008
-
$122.70K(-59.2%)
$423.20K(+40.8%)
Jun 2008
-
$300.50K(>+9900.0%)
$300.50K(>+9900.0%)
Feb 2008
-
$0.00(0.0%)
$0.00(0.0%)
Nov 2007
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Aug 2007
-
$0.00(0.0%)
$0.00(0.0%)
May 2007
-
$0.00(0.0%)
$0.00(0.0%)
Feb 2007
-
$0.00
$0.00
Nov 2006
$0.00
-
-

FAQ

  • What is Niagen Bioscience, Inc. annual capital expenditures?
  • What is the all-time high annual CAPEX for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. annual CAPEX year-on-year change?
  • What is Niagen Bioscience, Inc. quarterly capital expenditures?
  • What is the all-time high quarterly CAPEX for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. quarterly CAPEX year-on-year change?
  • What is Niagen Bioscience, Inc. TTM capital expenditures?
  • What is the all-time high TTM CAPEX for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. TTM CAPEX year-on-year change?

What is Niagen Bioscience, Inc. annual capital expenditures?

The current annual CAPEX of NAGE is $163.00K

What is the all-time high annual CAPEX for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high annual capital expenditures is $1.72M

What is Niagen Bioscience, Inc. annual CAPEX year-on-year change?

Over the past year, NAGE annual capital expenditures has changed by +$15.00K (+10.14%)

What is Niagen Bioscience, Inc. quarterly capital expenditures?

The current quarterly CAPEX of NAGE is $24.00K

What is the all-time high quarterly CAPEX for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high quarterly capital expenditures is $1.11M

What is Niagen Bioscience, Inc. quarterly CAPEX year-on-year change?

Over the past year, NAGE quarterly capital expenditures has changed by -$17.00K (-41.46%)

What is Niagen Bioscience, Inc. TTM capital expenditures?

The current TTM CAPEX of NAGE is $260.00K

What is the all-time high TTM CAPEX for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high TTM capital expenditures is $2.15M

What is Niagen Bioscience, Inc. TTM CAPEX year-on-year change?

Over the past year, NAGE TTM capital expenditures has changed by +$145.00K (+126.09%)
On this page